<i>Bifidobacterium bifidum</i>TMC3115 ameliorates milk protein allergy in by affecting gut microbiota: A randomized double‐blind control trial

Wei, Jing; Liu, Qingbin; Wang, Wei

doi:10.1111/jfbc.13489

Cited by 40 publications

(47 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Table 4 illustrates examples from human clinical trials [ 131 , 148 , 149 , 150 , 151 , 152 , 153 , 154 , 155 , 156 , 157 , 158 , 159 , 160 , 161 , 162 , 163 , 164 , 165 , 166 , 167 , 168 , 169 , 170 , 171 , 172 , 173 , 174 , 175 , 176 , 177 , 178 , 179 , 180 , 181 , 182 , 183 ]. Not surprisingly, the best outcomes occur when there is a clear understanding of the specific microbes, genes, metabolic changes, and installation conditions that are needed to support microbiome-driven physiological benefits.…”

Section: Probiotics Prebiotics and Targeted Rebiosis: Clinical And Preclinical Examplesmentioning

confidence: 99%

Microbiome First Medicine in Health and Safety

Dietert

2021

Biomedicines

View full text Add to dashboard Cite

Microbiome First Medicine is a suggested 21st century healthcare paradigm that prioritizes the entire human, the human superorganism, beginning with the microbiome. To date, much of medicine has protected and treated patients as if they were a single species. This has resulted in unintended damage to the microbiome and an epidemic of chronic disorders [e.g., noncommunicable diseases and conditions (NCDs)]. Along with NCDs came loss of colonization resistance, increased susceptibility to infectious diseases, and increasing multimorbidity and polypharmacy over the life course. To move toward sustainable healthcare, the human microbiome needs to be front and center. This paper presents microbiome-human physiology from the view of systems biology regulation. It also details the ongoing NCD epidemic including the role of existing drugs and other factors that damage the human microbiome. Examples are provided for two entryway NCDs, asthma and obesity, regarding their extensive network of comorbid NCDs. Finally, the challenges of ensuring safety for the microbiome are detailed. Under Microbiome-First Medicine and considering the importance of keystone bacteria and critical windows of development, changes in even a few microbiota-prioritized medical decisions could make a significant difference in health across the life course.

show abstract

Section: Probiotics Prebiotics and Targeted Rebiosis: Clinical And Preclinical Examplesmentioning

confidence: 99%

Microbiome First Medicine in Health and Safety

Dietert

2021

Biomedicines

View full text Add to dashboard Cite

show abstract

“…According to the studies of Ma et al [37], probiotic microbes such as Bacillus subtilis, Saccharamyces cerevisiae, and Enterococcus faecalis can enrich milk secretion in cows and an inhibition of the milk allergy reaction was noted by the administration of Bifidobacterium bifidum [38]. Studies also showed that by stimulating GH/IGF-1 hormone, both Bacillus subtilis and Bacillus amyloliquefaciens can upgrade intestinal maturation and growth competency [39].…”

Section: Probiotics In Ruminant Nutrition and Healthmentioning

confidence: 99%

Recent Advances in Probiotic Application in Animal Health and Nutrition: A Review

Bhogoju

Nahashon

2022

Agriculture

View full text Add to dashboard Cite

Biotechnological advances in animal health and nutrition continue to play a significant role in the improvement of animal health, growth, and production performance. These biotechnological advancements, especially the use of direct-fed microbials, also termed probiotics, those genetically modified and otherwise, have minimized many challenges facing livestock production around the world. Such advancements result in healthy animals and animal products, such as meat, for a growing population worldwide. Increasing demand for productivity, healthy animals, and consumer food safety concerns, especially those emanating from excessive use of antibiotics or growth promoters, are a driving force for investing in safer alternatives, such as probiotics. The advent of vastly diverse pathogens and bacterial organisms, some of which have acquired antimicrobial resistance due to therapeutic use of these antibiotics, has had a negative impact on the animal and food industries. Probiotics have been chosen as substitutes to counter this excessive use of antibiotics and antibiotic resistance. Over the last decade, probiotics have gained recognition, increased in importance, and stimulated growing interest in the animal health and nutrition industry. Probiotics are considered to be favorable live microorganisms by the host organism by maintaining microbial homeostasis and healthy gut, and can be a viable alternative to antibiotics in addition to providing other growth-promoting properties. Even though various studies describe the modes of action of probiotics, more research is needed to illuminate the exact mechanism of action of probiotics and how they benefit the host. This review describes the importance of probiotics in animal health, nutrition, and in growth and production performance. It also provides a thorough review of recent advances in probiotics research and application in animal health and nutrition and future directions on probiotic research to enhance animal performance.

show abstract

“…Modulation of the gut microbiota could also reduce the side-effects of COVID-19 vaccines. It has been shown that probiotics can effectively ameliorate allergy ( Jing et al, 2020 ). Several probiotics including B. longum , B. breve , L. plantarum , L. casei , L. fermentum and L. rhamnosus have been demonstrated to have anti-allergic effects through animal studies and clinical trials ( Shu et al, 2019 ).…”

Section: Approaches To Improve Gut Microbiota For Covid-19 Vaccinationsmentioning

confidence: 99%